ETC
IOVA icon

Exchange Traded Concepts’s Iovance Biotherapeutics IOVA Stock Holding History

Exchange Traded Concepts’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-34,061
Closed -$113K – 1460
2025
Q1 		$113K Buy
34,061
+16,990
+100% +$87.6K ﹤0.01% 1115
2024
Q4 		$126K Hold
17,071
– – ﹤0.01% 1102
2024
Q3 		$160K Buy
17,071
+1,776
+12% +$16.8K ﹤0.01% 1040
2024
Q2 		$123K Sell
15,295
-4,757
-24% -$51K ﹤0.01% 929
2024
Q1 		$297K Sell
20,052
-6,551
-25% -$76.2K 0.01% 799
2023
Q4 		$216K Buy
26,603
+6,746
+34% +$35.3K 0.01% 783
2023
Q3 		$90.3K Buy
19,857
+3,777
+23% +$24.7K ﹤0.01% 936
2023
Q2 		$113K Buy
+16,080
New +$115K ﹤0.01% 927

Other funds holding IOVA

MFM
MHR Fund Management New York $1.92B AUM 119.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Exchange Traded Concepts's IOVA Position: Q2 2025 in Review

Exchange Traded Concepts sold out of Iovance Biotherapeutics (IOVA) in Q2 2025, closing a stake of 34,061 shares — an estimated $113K sold.

Exchange Traded Concepts first reported a position in IOVA in Q2 2023 and held it in 8 quarters. The position peaked at $297K in Q1 2024. 254 funds tracked by Wall St. Rank hold IOVA as of Q2 2025.

  • Exchange Traded Concepts reported no remaining Iovance Biotherapeutics position as of Q2 2025 after selling out during the quarter.
  • Exchange Traded Concepts sold 34,061 Iovance Biotherapeutics shares in Q2 2025, an estimated $113K.
  • Exchange Traded Concepts first reported a position in Iovance Biotherapeutics in Q2 2023 and held it in 8 quarters.
  • Exchange Traded Concepts's Iovance Biotherapeutics position peaked at $297K in Q1 2024.
  • 254 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q2 2025.

Based on Exchange Traded Concepts's 13F filing for Q2 2025, filed 10 Jul 2025.